Loading clinical trials...
Loading clinical trials...
Some breast cancer cells make a protein called Human Epidermal Growth factor receptor 2 (HER2). Patients with HER2 positive (HER2+) breast cancer receive medicine that attacks HER2, which helps these ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT06708910 · HER2 Positive Breast Carcinoma
NCT06958627 · HER2 Positive Breast Cancer, Pyrotinib Treatment
NCT01785420 · Carcinoma Breast Stage I, HER2 Positive Breast Cancer
NCT06868758 · HER2 Positive Breast Carcinoma, Neoadjuvant Therapy
Memorial Sloan Kettering Cancer Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions